Micro pump for Parkinson's treatment from Gerresheimer subsidiary Sensile Medical receives European CE declaration of conformity

Duesseldorf/Olten (ots) -

- Cross reference: Full press release is available at
http://www.presseportal.de/dokumente -

A wearable micro pump from Sensile Medical has received EU
certification for the European market. A European pharma company has
obtained a CE declaration of conformity for the pump, which is
specially designed for the treatment of Parkinson's disease, and is
now bringing it to market. This is the first time a micro pump from
Gerresheimer subsidiary Sensile Medical has come into commercial use.

The micro pump is used in the treatment of advanced Parkinson's
disease. Its great benefit for patients relates to ease of use,
including features such as automatic filling with liquid medicine.
State-of-the-art technologies such as a color display, charging unit
and data storage help enhance therapy management. The handy-sized,
discreet pump comes with a leather bag for it to be worn on the
user's belt.

A prerequisite for market launch was the CE declaration of
conformity for medical devices. Now it has that, the pharma company
can bring the pump to market. Sensile Medical developed the micro
pump for Parkinson's disease treatment especially for the pharma
company concerned. It is one of currently five concrete customer
projects in various therapeutic areas.

"The CE declaration of conformity and market launch for the first
micro pump, in this case for Parkinson's treatment, marks a key
milestone for our subsidiary Sensile Medical. The deservedly strict
approval standards for patient-critical delivery systems of this kind
are now satisfied and market launch can begin. We are correspondingly
optimistic regarding further application areas for Sensile Medical's
micro pump technology," explained Andreas Schütte, Member of the
Management Board of Gerresheimer AG.

A personally programmable basal profile enables treatment to be
optimized for Parkinson's patients and ensures that they receive the
precise dosage they need. Likewise for the bolus rate: A patient can
cause the device to deliver a bolus at just one touch of a button.
Sensile Medical's patented SenseCore micro rotary piston pump at the
heart of the pump device ensures exceptionally safe, precise drug
delivery. An even greater level of safety is attained by eliminating
flow rate calculations.

"In developing the micro pump for Parkinson's treatment, we have
completed a highly ambitious project to exacting requirements that
improves treatment for patients. The device also comes with a large
number of different languages already on board, enabling its use in
many countries around the world," explained Derek Brandt, CEO of
Sensile Medical AG. Press Release September 27, 2018 Page 2 / 2

Contact:
Gerresheimer AG
Klaus-Bungert-Strasse 4
40468 Duesseldorf
Germany

Jens Kürten
Group Senior Director Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-Mail j.kuerten@gerresheimer.com
Website www.gerresheimer.com

Original-Content von: Gerresheimer AG, übermittelt durch news aktuell